Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Kaiser Permanente Branch Mandates All Employees, Even Pregnant Women, Take Vaccine

A branch of the Kaiser Permanente healthcare organization is…
Read more

Teacher Defends Pushing Critical Race Theory on Students, Calls Opponents Racist

An Illinois teacher has made waves by posting a Tik Tok video…
Read more

Texas Governor puts $250 Million Down Payment on a Border Wall

Texas Gov. Gregg Abbott has announced a $250 million down…
Read more